This month’s collection of fixes from Microsoft includes 86 patches — but at least there were no zero-day bugs.

Regeneron's PD-1 inhibitor Libtayo could find wider use for a form of skin cancer known as cutaneous squamous cell carcinoma after showing efficacy in a pivotal trial as adjuvant therapy for patients ...